Prognostic Nutritional Index is a valuable preoperative prognostic biomarker in Mexican patients surgically intervened on gastrointestinal stromal tumors: a retrospective cohort study.

Autor: Herrera-Goepfert R; Department of Pathology, Instituto Nacional de Cancerología, Av. San Fernando 22, Col. Sección XVI, Tlalpan, 14080, Ciudad de México, Mexico. rhgoepfert@gmail.com., Soca-Chafre G; Oncological Diseases Research Unit (UIEO), Hospital Infantil de México Federico Gómez (HIMFG), Mexico City, Mexico., Oñate-Ocaña LF; Clinical Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico., Montiel-Dávalos A; Basic Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico., Rodríguez-Maldonado E; Laboratory of Translational Cardiology, Research Unit UNAM-INC, Instituto Nacional de Cardiología, Mexico City, Mexico., Castro-Martínez E; Emergency Department, Instituto Nacional de Neurología y Neurocirugía 'Dr. Manuel Velasco Suárez', Mexico City, Mexico.; Internal Medicine Division, Hospital General Dr. Manuel Gea González, Mexico City, Mexico.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Dec 03; Vol. 33 (1), pp. 1. Date of Electronic Publication: 2024 Dec 03.

A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.

Autor: Blay JY; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr., Schiffler C; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Bouché O; CHU & Université de Reims, Reims, France., Brahmi M; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Duffaud F; Hôpital La Timone & Université Aix-Marseille, Marseille, France., Toulmonde M; Institut Bergonié, Bordeaux, France., Landi B; Hôpital Européen George Pompidou, Paris, France., Lahlou W; Hôpital Européen George Pompidou, Paris, France., Pannier D; Centre Oscar Lambret & Université Lille, Lille, France., Bompas E; Institut Cancérologie de l'Ouest, Nantes, France., Bertucci F; Institut Paoli-Calmette & Université Aix-Marseille, Marseille, France., Chaigneau L; CHU Besançon, Besançon, France., Collard O; Hôpital Privé de la Loire, Saint-Etienne, France., Pracht M; Centre Eugene Marquis, Rennes, France., Henon C; Institut Gustave Roussy, Villejuif, France., Ray-Coquard I; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Armoun K; CHU & Université de Reims, Reims, France., Salas S; Hôpital La Timone & Université Aix-Marseille, Marseille, France., Spalato-Ceruso M; Institut Bergonié, Bordeaux, France., Adenis A; Centre Oscar Lambret & Université Lille, Lille, France; Institut de Cancerologie de Montpellier & CLCC Val d'Aurelle, Montpellier, France., Verret B; Institut de Cancerologie de Montpellier & CLCC Val d'Aurelle, Montpellier, France., Penel N; Centre Oscar Lambret & Université Lille, Lille, France., Moreau-Bachelard C; Institut Cancérologie de l'Ouest, Nantes, France., Italiano A; Institut Bergonié, Bordeaux, France., Dufresne A; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Metzger S; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Chabaud S; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Perol D; Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Le Cesne A; Institut Gustave Roussy, Villejuif, France.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Dec; Vol. 35 (12), pp. 1157-1168. Date of Electronic Publication: 2024 Sep 04.

Prospective evaluation of quantitative response parameter in patients with Gastrointestinal Stroma Tumor undergoing tyrosine kinase inhibitor therapy-Impact on clinical outcome.

Autor: Meyer M; Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim-Heidelberg University, Mannheim, Germany.; Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA.; Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Ota H; Department of Diagnostic Radiology, Tohoku University Hospital, Miyagi, Japan., Messiou C; Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, London, UK., Benson C; The Royal Marsden Hospital NHS Foundation Trust, London, UK., Henzler T; Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim-Heidelberg University, Mannheim, Germany., Mattonen SA; Department of Medical Biophysics, Western University, London, Canada., Marin D; Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA., Bartsch A; Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim-Heidelberg University, Mannheim, Germany.; Department of Orthopedics and Traumatology, University Hospital Basel, Basel, Switzerland., Schoenberg SO; Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim-Heidelberg University, Mannheim, Germany., Riedel RF; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA., Hohenberger P; Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.

Publikováno v: International journal of cancer [Int J Cancer] 2024 Dec 01; Vol. 155 (11), pp. 2047-2057. Date of Electronic Publication: 2024 Jul 18.

Interpretable machine learning model based on CT semantic features and radiomics features to preoperatively predict Ki-67 expression in gastrointestinal stromal tumors.

Autor: Wang Y; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China., Bai G; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China., Liu Y; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China., Huang M; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China., Chen W; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China. wchen74@163.com., Wang F; Department of medical imaging, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, No.1, Huang he West Road, Huai'an, 223300, Jiangsu, China.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 26; Vol. 14 (1), pp. 29336. Date of Electronic Publication: 2024 Nov 26.

Single-cell integration reveals metaplasia in inflammatory gut diseases.

Autor: Oliver AJ; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Huang N; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Bartolome-Casado R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Department of Pathology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway., Li R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, US., Koplev S; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Nilsen HR; Department of Pathology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway., Moy M; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Cakir B; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Polanski K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Gudiño V; Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain., Melón-Ardanaz E; Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain., Sumanaweera D; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Dimitrov D; Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Bioquant, Heidelberg, Germany., Milchsack LM; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., FitzPatrick MEB; Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Provine NM; Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Boccacino JM; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Dann E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Predeus AV; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., To K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Prete M; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Chapman JA; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Masi AC; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Stephenson E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Engelbert J; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Lobentanzer S; Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Bioquant, Heidelberg, Germany., Perera S; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Richardson L; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Kapuge R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Wilbrey-Clark A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Semprich CI; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Ellams S; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Tudor C; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Joseph P; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Garrido-Trigo A; Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain., Corraliza AM; Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain., Oliver TRW; Department of Histopathology and Cytology, Cambridge University Hospitals, Cambridge, UK., Hook CE; Department of Pathology, University of Cambridge, Cambridge, UK., James KR; Translational Genomics, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia., Mahbubani KT; Department of Surgery, University of Cambridge, Cambridge, UK.; Cambridge Biorepository for Translational Medicine, Cambridge NIHR Biomedical Research Centre, Cambridge, UK.; Department of Haematology, Cambridge Stem Cell Institute, Cambridge, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge, Cambridge, UK.; Cambridge Biorepository for Translational Medicine, Cambridge NIHR Biomedical Research Centre, Cambridge, UK., Zilbauer M; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; University Department of Paediatrics, University of Cambridge, Cambridge, UK.; Department of Paediatric Gastroenterology, Hepatology and Nutrition, Cambridge University Hospitals, Cambridge, UK., Saez-Rodriguez J; Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Heidelberg University Hospital, Bioquant, Heidelberg, Germany., Høivik ML; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bækkevold ES; Department of Pathology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway., Stewart CJ; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Berrington JE; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Meyer KB; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK., Klenerman P; Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Salas A; Inflammatory Bowel Disease Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain., Haniffa M; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Dermatology and National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Jahnsen FL; Department of Pathology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo, Norway., Elmentaite R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Cambridge, UK., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. sat1003@cam.ac.uk.; Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.; Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Cambridge, UK. sat1003@cam.ac.uk.; Theory of Condensed Matter, Cavendish Laboratory/Department of Physics, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.; CIFAR Macmillan Multi-scale Human Program, CIFAR, Toronto, Ontario, Canada. sat1003@cam.ac.uk.

Publikováno v: Nature [Nature] 2024 Nov; Vol. 635 (8039), pp. 699-707. Date of Electronic Publication: 2024 Nov 20.